How often have you pulled out old MCU-based project that still works fine, but you have no idea where the original source ...
TechRadar Pro created this content as part of a paid partnership with RS. The content of this article is entirely independent and solely reflects the editorial opinion of TechRadar Pro. You've ...
HINGHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it is ...
From first-quarter lulls to impossible catches, here’s why every Super Bowl feels like it was written in advance – even when it isn’t. Let's clear the air before you read another word: I do not ...
For those who believe in the conspiracy theory that the NFL is "scripted"—i.e., that league execs decide which teams will see success before the season even starts—Monday was a big day on the internet ...
Microbot Medical is transitioning from R&D to commercialization with its LIBERTY single-use robotic system for endovascular interventions. I assign MBOT a neutral rating with a 1-year price target of ...
James Gunn publicly released the full screenplay of Superman on January 21, 2026. He posted, “For your enjoyment, the Superman screenplay,” on X (@JamesGunn), along with a link to the screenplay on ...
What if you could combine the simplicity of Arduino with the power of a Linux-based processor, all in one compact device? Enter the Arduino Uno Q, a new development board designed to handle everything ...
Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 453.85% Upside As of November 17 ...
Some members of the maker community are distraught about Arduino’s new terms of service (ToS), saying that the added rules put the company’s open source DNA at ...
Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...
Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results